pharmaceutical anticounterfeiting
How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?
January 26 by Pharma IQCases of counterfeit pharmaceuticals being discovered entering the United States are on the up.Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures...
How to Successfully Use Anti-Counterfeiting Technologies to Reduce Costs and Increase Your Business Value
June 08 by Pharma IQ"Fraudulent medicines offer organised criminal groups a high return commodity with relatively low risks, ultimately at the expense of the health of unsuspecting people," Yury Fedotov, executive direct...
Assessing the Impact of Globalisation on Pharmaceutical Counterfeiting
April 25 by Jeffrey GrenJeffrey Gren, Director of the Office of Health and Consumer Goods, joins Pharma IQ to address some solutions to the increase in the volume and the level of sophistication of counterfeiting as part of...